Pathophysiological topography of acute ischemia by combined diffusion- weighted and perfusion MRI

Stroke

Volumn 30, Issue 10, 1999, Pages 2043-2052

  Darby, D G ^b   Barber, P A ^b   Gerraty, R P ^b   Desmond, P M ^b   Yang, Q ^b   Parsons, M ^b   Li, T ^b   Tress, B M ^b   Davis, Stephen ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b NONE

Author keywords

Cerebral ischemia; Diffusion; Echo planar imaging; Perfusion

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN MAPPING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE CEREBRAL ARTERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSTERIOR CEREBRAL ARTERY; PRIORITY JOURNAL; STROKE;

EID: 0032860798     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.10.2043     Document Type: Article

References (42)

1. The National Institute of Neurological Disorders and Stroke rTPA Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, Henerici M. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
3. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P, for the Second European-Australasian Acute Stroke Study I. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352:1245-1251.
4. Moseley ME, Kucharczyk J, Mintorovitch J, Cohen Y, Kurhanewicz J, Derugin N, Asgari H, Norman D. Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol. 1990;11: 423-429.
5. Mintorovitch J, Moseley ME, Chileuitt L, Shimizu H, Cohen Y, Weinstein PR. Early detection of cerebral ischaemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med. 1990;14:330-346.
6. Mintorovitch J, Moseley ME, Chileuitt L, Shimizu H, Cohen Y, Weinstein PR. Comparison of diffusion- and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn Reson Med. 1991;18:39-50.
7. Barber PA, Darby DG, Desmond PM, Yang Q, Gerraty RP, Jolley D, Donnan GA, Tress BM, Davis SM. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted magnetic resonance imaging. Neurology. 1998;51:418-426.
8. Lecouvet FE, Duprez TPJ, Raymackers JM, Peeters A, Cosnard G. Resolution of early diffusion-weighted and FLAIR MRI abnormalities in a patient with TIA. Neurology. 1999;52:1085-1087.
9. Astrup J, Symon L, Siesjo BK. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke. 1981;12:723-725.
10. Warach S, Wielopolski P, Edelman R. Identification and characterization of the ischemic penumbra of acute human stroke using echoplanar diffusion and perfusion imaging. In: Proceedings of the 12th Annual Scientific Meeting of the Society of Magnetic Resonance Medicine; 1993; Berkeley, Calif. Abstract, p 263.
11. Marks MP, Tong DC, Beaulieu C, Albers GW, de Crespigny A, Moseley ME. Evaluation of early reperfusion and tPA therapy using diffusion- and perfusion-weighted MRI. Neurology. 1999;52:1792-1798.
12. Barber PA, Darby DG, Desmond PM, Yang Q, Gerraty RP, Jolley D, Donnan GA, Tress BM, Davis SM. Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra. Neurology. 1999;52:1125-1132.
13. Baird AE, Benfield A, Schlaug G, Siewert B, Lovblad K, Edelman R, Warach S. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol. 1997;41:581-589.
14. Sorensen AG, Buonanno FS, Gonzalez RG, Schwamm LH, Lev MH, Huang-Hellinger FR, Reese TG, Weisskoff RM, Davis TL, Suwanwela N, Can U, Moreira JA, Copen WA, Look RB, Finklestein SP, Rosen BR, Koroshetz WJ. Hyperacute stroke: evaluation with combined multisection diffusion-eighted and hemodynamically weighted echo-planar MR imaging. Radiology. 1996;199:391-401.
15. Fisher M, Albers GW. Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke. Neurology. 1999;52: 1750-1756.
16. Prichard JW, Grossman RI. New reasons for early use of MRI in stroke. Neurology. 1999;52:1733-1736.
17. Barber PA, Davis SM, Infeld B, Baird AE, Donnan GA, Jolley D, Lichtenstein M. Spontaneous reperfusion following ischemic stroke is associated with improved outcome. Stroke. 1998;29:2522-2528.
18. Stejskal E, Tanner J. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys. 1965;42: 288-292.
19. Ulug AM, Beauchamp N Jr, Bryan RN, van Zijl PC. Absolute quantitation of diffusion constants in human stroke. Stroke. 1997;28:483-490.
20. van Gelderen P, de Vleeschouwer MHM, Des Pres D, Pekar J, van Zijl PCM. Water diffusion and acute stroke. Magn Reson Med. 1994;31: 154-163.
21. Lassen NA, Henriksen O, Sejrsen P. Indicator methods for measurement of organ and tissue blood flow. In: Shepherd JT, Abboud FM, eds. Handbook of Physiology. Bethesda, Md: American Physiological Society; 1983.
22. Hennerici M, Daffertshofer M, Jakobs L. Failure to identify cerebral infarct mechanisms from topography of vascular lesions. AJNR Am J Neuroradiol. 1998;19:1067-1074.
23. Bladin CF, Chambers BR. Frequency and pathogenesis of hemodynamic stroke. Stroke. 1994;25:2179-2182.
24. Bladin CF, Chambers BR. Clinical features, pathogenesis, and computed tomographic characteristics of internal watershed infarction. Stroke. 1993;24:1925-1932.
25. The Multicentre Acute Stroke Trial-Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med. 1996;335:145-150.
26. Multicentre Acute Stroke Trial-Italy Group. Randomised controlled trial of streptokinase, aspirin and combination of both in treatment of acute ischaemic stroke. Lancet. 1995;346:1509-1514.
27. Donnan GA, Davis SM, Chambers BR, Gates PC, Hankey GJ, McNeil JJ, Rosen D, Stewart-Wynne EG, Tuck RR. Streptokinase for acute ischaemic stroke with relationship to time of administration. JAMA. 1996;276:961-966.
28. Furlan M, Marchal G, Viader F, Derlon JM, Baron JC. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol. 1996;40:216-226.
29. Marchal G, Beaudouin V, Rioux P, de la Sayette V, Le Doze F, Viader F, Derlon JM, Baron JC. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel based data analysis. Stroke. 1996;27:599-606.
30. Koroshetz WJ, Gonzalez G. Diffusion-weighted MRI: an ECG for "brain attack"? Ann Neurol. 1997;41:565-566.
31. Du C, Hu R, Csernansky CA, Hsu CY, Choi DW. Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J Cereb Blood Flow Metab. 1996;16:195-201.
32. Ay H, Buonanno FS, Rordorf G, Schaefer PW, Schwamm LH, Wu O, Gonzalez RG, Yamada K, Sorensen GA, Koroshetz WJ. Normal diffusion-weighted MRI during stroke-like deficits. Neurology. 1999;52: 1784-1792.
33. Tong DC, Yenari MA, Albers GW, O'Brien M, Marks MP, Moseley ME. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology. 1998;50:864-870.
34. Powers WJ, Zivin JA. Magnetic resonance imaging in acute stroke: not ready for prime time. Neurology. 1998;50:842-843.
35. Mohr JP, Gautier JC, Hier DB. Middle Cerebral Artery Disease. New York, NY: Churchill Livingstone Inc; 1992.
36. Truwit CL, Barkovich AJ, Gean-Marton A, Hibri N, Norman D. Loss of the insular ribbon: another early sign of acute middle cerebral artery infarction. Radiology. 1990;176:801-806.
37. Beckstead JE, Tweed WA, Lee J, MacKeen WL. Cerebral blood flow and metabolism in man following cardiac arrest. Stroke. 1978;9:569-573.
38. Donnan GA, Bladin PF, Berkovic SF, Longley WA, Saling MM. The stroke syndrome of striatocapsular infarction. Brain. 1991;114:51-71.
39. Lassen NA. The luxury perfusion syndrome and its possible relation to acute metabolic acidosis localized within the brain. Lancet. 1966;2: 1113-1115.
40. Hossman K. Viability thresholds and the penumbra of focal ischemia. Ann Neurol. 1994;36:557-565.
41. 14C]2-deoxyglucose phosphorylation. J Cereb Blood Flow Metab. 1986;6:607-615.
42. Takano K, Formato JE, Carano RAD, Helmer KG, Hasegawa Y, Sotak C, Fisher M. The role of spreading depression in focal ischemia evaluated by diffusion mapping. Ann Neurol. 1996;39:308-318.